Nexalin Technology (NXL) vs QT Imaging (QTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 11, 2026.
Summary
QT Imaging is the larger company by market cap ($39.2 million vs $3.8 million), about 10.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NXL | QTI |
|---|---|---|
| Share price | $3.63 | $2.68 |
| Market cap | $3.81M | $39.23M |
| 1-day change | -11.68% | +3.08% |
| YTD return | — | -56.07% |
| 1-year return | — | -92.06% |
| EPS (TTM) | $-14.10 | $-1.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.70 | $36.75 |
| 52-week low | $3.50 | $2.42 |
| Distance from 52-week high | -92.84% | -92.71% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +313.22% | +288.06% |
| Average volume | 1.02M | 36.92K |
| Shares outstanding | 1.05M | 14.64M |
| Employees | 8 | 31 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QT Imaging is about 10.3 times larger than Nexalin Technology by market value ($39.23M vs $3.81M).
About Nexalin Technology
NXL stock →Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 8 employees
About QT Imaging
QTI stock →QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 31 employees
NXL vs QTI FAQ
Which is bigger, Nexalin Technology or QT Imaging?
QT Imaging (QTI) is larger, with a market capitalization of $39.23M compared with $3.81M for Nexalin Technology (NXL).
Are Nexalin Technology and QT Imaging in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.